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ABSTRACT
Objectives: Less radical fertility sparing procedures have been introduced to reduce morbidity and adverse obstetric 
outcome in cervical cancer. Our objective was to describe oncological and obstetric outcomes of women with early-stage 
cervical cancer who underwent a simple vaginal trachelectomy (SVT). 
Material and methods: From 01/2013 to 05/2017, 14 women underwent SVT preceded by laparoscopic pelvic lymph 
node dissection. 
Results: Patients’ median age was 32 years and all of them were nulliparous. Histology included squamous cell carcinoma 
and adenocarcinoma in 12 (85.7%) and 2 (14.3%) patients, respectively. Three patients had stage 1A1 with lymphovascular 
space invasion, 4 1A2 and 7 1B1. After obtaining final histopathology, one patient underwent radical hysterectomy due to 
positive surgical margin and excluded from analysis. None of the patients had lymph node metastasis. None of the 13 pa-
tients developed a recurrence within a median follow-up of 27 (6–56) months. Seven patients have conceived: 4 were term 
deliveries, 2 were late preterm deliveries and 1 was spontaneous abortion.
Conclusions: SVT in well selected early-stage cervical cancer patients seems to be a safe treatment option with excellent 
oncologic outcome, preserving reproductive function. Literature data will need to be confirmed in large prospective series.
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INTRODUCTION
Cervical cancer represents the second common malig-
nancy in women worldwide, with an estimated 500,000 new 
cases and 275,000 related deaths annually [1]. In devel-
oped countries women tend to delay birth of first child until 
the age at the female reproductive capacity has started to 
decrease. Therefore, the number of patients with cervical 
cancer who desire fertility has been increased. 
Radical hysterectomy with pelvic lymphadenectomy has 
been the standart treatment of stage 1A2 and 1B1 cervical 
cancer. However, radical trachelectomy, performed either 
by vaginal and abdominal route, represents as an effective 
treatment option with a survival rate of 95–98% in patients 
who desire fertility [2, 3]. Many guidelines propose radical 
trachelectomy with lymphadenectomy for early cervical 
cancer patients who wish to preserve fertility [4–6]. However, 
radical trachelectomy has some morbidities. Removal of un-
necessary endocervical canal may lead to cervical stenosis 
in those patients [7]. Abortion and second trimester miscar-
riages are more than 70% in patients underwent abdomi-
nal radical trachelectomy. In addition, parametrectomy is 
responsible for the majority of surgical complications such 
as intraoperative significant blood loss, bladder and bowel 
dysfunction, fistula formation, and sexual dysfunction [7, 8]. 
On the other hand, very low rate of parametrial involvement 
and recurrence in patients with cervical tumor ≤ 2 cm has 
been reported in many studies [9–11]. Analysis of more 
than 1000 cervical cancer cases with lesions measuring 
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less than 2 cm found that the risk of parametrial infiltration 
is < 1% in this group of patients [10]. Retrospective data of 
507 patients with stage 1B or 2A disease who underwent 
radical hysterectomy and pelvic lymphadenectomy revealed 
that patients having all of the following three pathological 
factors, inner 1/3 stromal invasion and no lymphovascular 
space invasion (LVSI) and squamous histology, had 1.1% 
risk of parametrial involvement [11]. A very recent series of 
345 patients showed that none of the patients with tumor 
size less than 2 cm and no LVSI had parametrial involvement 
[12]. A retrospective review of 260 patients with early-stage 
cervical cancer managed with either simple hysterectomy 
or simple trachelectomy/conization and lymph node dis-
section demonstrated only 2 recurrences and 1 death in 
node-negative patients [13]. Standing these data, parame-
trectomy is highly questionable for many patients having 
cervical cancer ≤ 2 cm. Thus, radicality of trachelectomy 
may be considered as unnecessary for this group of pa-
tients. While the parametrium and vaginal cuff along with 
cervix are removed during radical trachelectomy, simple 
vaginal trachelectomy (SVT) involves a supravaginal am-
putation of the cervix. 
In this study, we describe our experiences with SVT in 
carefully selected cervical cancer patients with its oncologi-
cal and obstetrical outcomes. 
MATERIAL AND METHODS
Women who underwent less radical fertility spar-
ing surgery for cervical cancer between 01/2013 and 
05/2017 were retrospectively reviewed. The data, includ-
ing age, parity, tumor size, histology and grade of the 
tumor, stage of the disease, presence of LVSI, pathologi-
cal margins on diagnostic procedure and SVT follow-up 
evaluations were obtained from manuel reviews of pa-
tients’ medical charts. Histologic type, grade and LVSI 
were determined by biopsy or LEEP. Tumor size was calcu-
lated using the findings from gynecological examination, 
transvaginal ultrasound and pelvic magnetic resonance 
imaging (MRI). Nodal status was assessed by Positron 
Emission Tomography (PET) scan.
Indications for different fertility sparing surgery proce-
dures were discussed with patients from generally accepted 
to experimental. All patients were informed that the simple 
trachelectomy may be abandoned if any metastatic node 
was identified during laparoscopy.
All surgeries started with laparoscopic pelvic sentinel 
lymph node (SLN) mapping using methylene blue dye. SLNs 
were sent to frozen section evaluation. In the first 8 patients, 
complete bilateral pelvic lymphadenectomy was performed 
subsequently. The rest of the patients underwent only SLN 
mapping. If any sentinel lymph node was positive, SVT 
would be cancelled and laparoscopic paraaortic lymphad-
enectomy would be planned. After negative frozen section 
result, SVT was performed in accordance with simple vagi-
nal hysterectomy principle. SVT involved the amputation 
of the cervix and ligation of bilateral cervical branches of 
uterine arteries. The specimen was sent to frozen section for 
evaluation of the surgical margins. Then, isthmic edges were 
sutured to the vaginal edges. No cerclage was placed at the 
end of the procedure. Radical hysterectomy was planned in 
the presence of positive surgical margin. Ultrastaging study 
was performed for the SLNs.
All biopsy, LEEP and trachelectomy specimens were 
reviewed by same gynecopathologist. Patients were fol-
lowed up at 4-months intervals for the first 2 years, then 
semiannually. Each visit included physical and gynecologi-
cal examinations along with transvaginal ultrasonography, 
colposcopy and a vaginal cytology.
A detailed written informed consent was obtained from 
patients who opted for an experimental, less radical ap-
proach. The study was approved by the Ethics Committee 
of Istanbul University Cerrahpasa Faculty of Medicine.
Standart descriptive statistics were applied in the analy-
sis. Statistical Package for the Social Sciences (SPSS) version 
16.0 (SPSS Inc., Chicago, IL, USA) was used.
RESULTS
Fourteen women selected as candidates for SVT. None 
of them had a tumor larger than 20 mm on MRI or pelvic 
examination. None of them had a suspicious lymph node 
on PET scan. Of these, 13 women successfully completed 
fertility sparing surgery. One patient had positive surgical 
margin on final pathology and underwent laparoscopic radi-
cal hysterectomy and ovarian transposition. Clinicopatho-
logical characteristics of the study cohort are presented in 
Table 1. The median age of the patients was 32 (27–36); all 
of them were nulliparous. Most of the patients had squa-
mous cell carcinoma. Cervical cancer was diagnosed from 
LEEP and punch biopsy in 10 and 3 patients, respectively. In 
one patient, cervical adenocarcinoma was diagnosed from 
cervical polypectomy.
The median operative time was 140 minutes (110–
200 minutes). No significant blood loss occured. There were 
no intraoperative or postoperative complications.
No recurrences occured within the median duration 
follow-up of 27 months (6–56 months). All follow-up cytol-
ogy tests turned negative. 
Among 11 women attempted to conceive, 7 patients 
have become pregnant spontaneously so far (63.6%) 
(Tab. 2). From them, 1 had a spontaneous abortion 
in first trimester. 4 women successfully delivered at 
term. Two patients delivered in the 35th and 34th week 
of their pregnancies. All of the deliveries were cesar-
ean sections. 
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DISCUSSION
Our study presents a cohort of patients with stage 
1A2-1B1 cervical cancer who underwent SVT and laparo-
scopic pelvic lymphadenectomy. Median age of the 14 pa-
tients was 32 and all of them were nulliparous. The majority 
had stage 1B1 disease (50%), squamous histology (85%) 
and grade 1 or 2 lesions (93%). Eight patients underwent 
laparoscopic SLN mapping followed by complete lymphad-
enectomy on both pelvic sides irrespective of whether the 
SLN was found. SLNs were found unilaterally in 3 patients 
and bilaterally in 5 patients. In our clinic, completion pelvic 
lymphadenecomy has not been performed since August 
2015 if SLNs was detected on both pelvic sides. The remain-
ing 6 patients underwent only laparoscopic SLN mapping. 
Complete pelvic lymphadenectomy was not performed 
as at least one SLN was found per hemi-pelvises in these 
patients. In their study involving cervical cancer patients, 
Cibula et al. [14] performed ultrastaging to both sentinel and 
non-sentinel lymph nodes and found that there is no risk 
of occult metastasis on non-SLNs when SLNs are negative. 
In the present study, ultrastaging of SLNs resulted negative 
in every patients and pathologic evaluation of non-SLNs 
showed no metastasis in the first 8 patients.
The oncological outcomes of radical trachelectomy was 
shown to be comparable with radical hysterectomy [2]. How-
ever, oncologic safety of simple trachelectomy still remains 
debatable. In our series, with a median follow-up time of 
27 months, there has been no recurrence so far. Oncologic 
outcome of our patients is similar to the literature. A previ-
ous study reported only 1 central invasive recurrence (3.2%) 
out of 31 patients treated with SVT [15]. Another series 
showed 2 invasive recurrences in 38 patients who under-
went large loop conization and pelvic lymphadecentomy 
[16]. Both studies included cervical cancer patients with 
tumors smaller than 2 cm. A recent case series of 32 patients 
with stage 1A2–1B2 disease who underwent conization 
or simple trachelectomy reported an invasive recurrence 
rate of 12.5% (four of 32 patients). However, 10 patients 
received neoadjuvant chemotherapy and 3 out of 4 invasive 
recurrences were within the neoadjuvant chemotherapy 
group [17]. A multicenter study from Italy included 36 stage 
1B1 cervical cancer cases treated with conization and lym-
phadenectomy [18]. Fourteen percent of the patients had 
grade 3 disease and 14% had LVSI. One pelvic lymph node 
recurrence occured within 66 months follow-up time. In 
their first report, Plante et al. [19] reported no recurrence 
in 16 patients with low risk, early-stage cervical cancer 
(< 2 cm) who underwent SVT with SLN mapping and/or 
pelvic lymph node dissection within 27 months follow-up 
time. Four years later, they presented a larger series of SVT 
including a total of 35 patients (n = 8: stage 1A1 with LVSI; 
n = 9: stage 1A2; n = 18: stage 1B1). They reported only one 
local recurrence [19].
Among our patients, 7 women have become pregnant. 
First trimester loss occured in one patient, 2 delivered at 
34 and 35 weeks, and 4 delivered at term (> 37 weeks). Our 
obstetric outcome is in keeping with the literature. Plante 
et al. [20] reported 18 term and 2 preterm births in 35 pa-
tients who underwent SVT with a median follow-up time of 
42 months. A large, systematic review comparing obstetric 
outcomes of radical and simple trachelectomy found that, 
Table 2. Obstetric outcomes of the 13 patients
n (%)
Attempted to conceive 11 (84.6)
Patients achieved pregnancy 7 (63.6)
Pregnancy results
 Term birth (≥ 37 weeks)
 Preterm birth 
 Second trimester miscarriage
 First trimester loss
n
4
2 
0
1
Table 1. Clinicopathological characteristics of the patients
Median (range)
Age [year] 32 (27–37)
n (%)
Parity
 0
 1
14 (100)
0
Histology
 Squamous
 Adenocarcinoma
12 (85.7)
2 (14.3)
Grade
 1
 2
 3
 
6 (42.8)
7 (50)
1 (7.1)
Stage
 1A1 with LVSI 
 1A2
 1B1
3 (21.4)
4 (28.5)
7 (50)
LVSI
 No
 Yes
7 (50)
7 (50)
Diagnostic procedure
 Punch bx
 LEEP
 Polyp excision
3 (21.4)
10 (71.4)
1 (7.1)
Pathological margins on diagnostic procedure
 Negative
 Positive
1 (7.1)
13 (92.9)
Pathological margins on SVT specimen
 Negative
 Positive
13 (92.9)
 1 (7.1)
LVSI — lymphovascular space invasion; Bx — biopsy; LEEP — loop 
electrosurgical excision procedure; SVT — simple vaginal trachelectomy
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the prematurity rate is significantly lower in patients who 
underwent SVT or conization compared to vaginal or ab-
dominal radical trachelectomy [21]. 
Slama et al. [17] pointed out the importance of selection 
of the patients with an active attitude to their reproductive 
plans, in order to avoid risk of recurrences and death in 
a group of patients with excellent outcome after standart 
procedure. In their study, half of the patients did not con-
sider pregnancy for a reason after conization or simple 
trachelectomy for cervical cancer. Clearly, careful patient 
selection is of paramount importance. We agree with Plante 
[22] that these cases should be evaluated and managed by 
gynecologic oncologists. 
To date, less than 400 women with early-stage cervical 
cancer managed with conservative fertility sparing surgery 
(conization or simple trachelectomy with pelvic lymphad-
enectomy) have been described in the literature. Table 
3 summarizes the detailed data of these series. Among them, 
there were 3 patients with a histologic type other than squ-
mous, adeno- or adenosquamous carcinoma (clear cell, 
glassy and undifferantiated types). Most women had stage 
1B1 disease. Only one patient had a tumor larger than 2 cm. 
Median follow up time ranged from 16 to 66 months. Recur-
rence rate among shown studies was about 4%. Ninety-eight 
live births with > 70% being term,among 245 women at-
tempted to concieve have been reported. 
Currently, there are ongoing one randomised clinical 
trial (the SHAPE trial) and two prospective cohort studies 
(ConCerv and GOG-278) evaluating the safety of less radical 
surgery in patients with low-risk early-stage cervical cancer 
[27–29]. These trials will provide more concrete evidence 
on this issue.
CONCLUSIONS
In conclusion, SVT can be an effective treatment option 
in selected group of cervical cancer patients who strongly 
desire fertility preservation. Based on existing literature 
and our data, we suggest performing SVT to patients with 
cervical tumors 2 cm or less in diameter. Results of three 
ongoing prospective studies should be waited to reach 
more reliable conclusion.
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